Acknowledgement
- PDF / 56,033 Bytes
- 1 Pages / 612 x 794 pts Page_size
- 30 Downloads / 138 Views
Pharm Med 2010; 24 (6): 337 1178-2595/10/0006-0337/$49.95/0
ª 2010 Adis Data Information BV. All rights reserved.
Dear Reader As we reach the final issue of the year for Pharmaceutical Medicine, we hope that you have found the articles published throughout 2010 to be both interesting and informative. The editors and publishing staff have appreciated the high quality of content contributed to the journal this year and look forward to keeping you up to date with topical issues in the field of Pharmaceutical Medicine in 2011. We are also pleased to advise you of a number of important developments to affect the Adis journals portfolio in 2010. This year saw Drugs in R&D being transformed from subscription based to open access, making it the first Adis journal to embrace the open-access model. Pediatric Drugs was accepted for inclusion in Current Contents/Clinical Medicine and a Thompson ISI impact factor (IF) for the journal is expected in 2013. This year, we also celebrated the 10th anniversary of the American Journal of Clinical Dermatology making significant contributions to the field of dermatology. The high quality of Adis journals was further recognized in the new ISI IFs for 2009, with ten of our titles making strong IF gains over 2008. The most impressive gains were made by BioDrugs (IF 3.506) – up more than 55%, and Drugs in R&D (IF 1.354), which was up more than 35%. Other standout performers include Drugs (IF 4.732), up 14%, and the American Journal of Clinical Dermatology (IF 1.820), up 17%. Impressive IF gains were also registered for Clinical Pharmacokinetics (4.560), CNS Drugs (3.879), Sports Medicine (3.118), Drugs & Aging (2.209), Molecular Diagnosis and Therapy (2.167) and Clinical Drug Investigation (1.414). The American Journal of Cardiovascular Drugs, a newly tracked journal in 2009, received its first IF (1.964) and was ranked #47 in the ‘Cardiac & Cardiovascular System’ category. Last, but not least, we would like to say a big thank you to all the authors who have contributed articles to Pharmaceutical Medicine in the last 12 months. Without their hard work and diligence we would not have been able to publish the journal. The quality of published articles also reflects the significant time and effort dedicated by the peer reviewers, who ensure that we continue to publish content of the highest possible standard. In addition to the members of our Honorary Editorial Board, we would like to thank the following individuals who acted as referees for articles published in Pharmaceutical Medicine in 2010: Fabio Angeli, Italy Michael Barratt, UK Jane Barrett, UK Robert A. Bell, USA Thomas D. Bethke, Germany Trevor Cook, UK Will G. Dixon, UK Brian D. Edwards, UK Luciano M. Fuccella, Italy Stevan Gressitt, USA Craig Hartford, UK Alan M. Hochberg, Switzerland Jisu Huh, USA Bonnie Kaplan, Canada Ivar S. Kristiansen, Norway Michael N. Liebman, USA Stephen Little, UK Radica Manasijevic, Germany
Tomohiro T. Morita, Japan Joaquin F. Mould-Quevedo, Mexico Roland I. Orre, Sweden Nickolas Papadopoulos, USA Maart
Data Loading...
